Loading stock data…
$0.80-0.05 (-5.61%)
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.
Hyperfine, Inc. in the Healthcare sector is trading at $0.80 with a market capitalization of $86M. Wall Street consensus targets $2.03 (3 analysts), implying a +153.0% move over the next 12 months. The stock is currently near its 52-week low of $0.75, remaining 30.1% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.90M | $3.90M↓ | $5.29M↑ | $3.44M↑ | $2.70M |
| Gross Profit | $1.98M | $1.98M↓ | $2.69M↑ | $1.85M↑ | $1.33M |
| Operating Income | -$8.47M↑ | -$8.56M↓ | -$7.67M↑ | -$8.92M↑ | -$9.60M |
| Net Income | -$9.30M↓ | -$8.62M↓ | -$5.91M↑ | -$11.02M↓ | -$9.22M |
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than...